Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Protective neutralizing antibodies from human survivors of Crimean-Congo hemorrhagic fever

Cell(2021)10.1016/j.cell.2021.05.001Source: DataRank Database

Protective neutralizing antibodies from human survivors of Crimean-Congo hemorrhagic fever is a research paper published in Cell (2021). On theSindex it has a DataRank of 0. It has been cited 94 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access94 citations

Download PDF

Cite:

Linked data & code

cellosaurus gen refseq pdb doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)OA: bronzeTopics (56)Linked Datasets (8)DataCite Reuse (8)IDs (PubMed, PMC)Annotations (5)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (29)

Daniel P. Maurer ORCID,Andrew S. Herbert ORCID,Ariel S. Wirchnianski ORCID,Olivia Vergnolle,Robert W. Cross ORCID

Live enrichment

PubMed:34077751 PMC:PMC8559771

NIAID NIH HHS

Grant: U19 AI142777

NIAID NIH HHS

Grant: T32 AI070117

NIGMS NIH HHS

Grant: T32 GM149438

NIAID NIH HHS

Grant: R01 AI132246

National Institutes of Health

Grant: 5R01AI132246-03

Preclinical Development of Human Monoclonal Antibodies for Postexposure Treatment of Crimean-Congo Hemorrhagic Fever

French National Research Agency (ANR)

Grant: ANR-13-ISV8-0002

E protein interactions in flavivirus membrane fusion

National Institutes of Health

Grant: 5T32AI070117-11

Geographic Medicine and Emerging Infections

National Institutes of Health

Grant: 5U19AI142777-04

Prometheus: A Platform for Rapid Development of Human Antibody-based Therapeutics and Prophylactics against Emerging Viral Threats

National Institutes of Health

bronzeLicense: Elsevier Non-Commercial

publisherhttp://www.cell.com/article/S0092867421005845/pdf

publisherhttps://api.elsevier.com/content/article/PII:S0092867421005845?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0092867421005845?httpAccept=text/plain

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8559771

https://doi.org/10.1016/j.cell.2021.05.001

Fields of Study

0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

Vero CellsAnimalsHumansMiceHemorrhagic Fever Virus, Crimean-CongoHemorrhagic Fever, CrimeanImmunoglobulin GRecombinant ProteinsViral ProteinsAntibodies, MonoclonalAntigens, ViralEpitopesNeutralization TestsProtein EngineeringEpitope MappingAmino Acid SequenceProtein BindingSurvivorsFemaleMaleBiophysical PhenomenaAntibodies, NeutralizingChlorocebus aethiops

Keywords

Monoclonal antibodyHuman monoclonal antibodyNairovirusEmerging VirusBunyavirusViral GlycoproteinTickborneCchfvCrimean-congo Hemorrhagic Fever VirusAntibody TherapeuticMaleAntibodies, MonoclonalProtein EngineeringAntibodies, NeutralizingBiophysical PhenomenaRecombinant ProteinsEpitopesMiceNeutralization TestsImmunoglobulin GChlorocebus aethiopsHemorrhagic Fever Virus, Crimean-CongoAnimalsHumansFemaleHemorrhagic Fever, CrimeanAmino Acid SequenceAntigens, ViralEpitope MappingProtein Binding

Sustainable Development Goals

SDG 3: 3. Good health

Additional file 3 of Comparative characterization of Crimean-Congo hemorrhagic fever virus cell culture systems with application to propagation and titration methods

10.6084/m9.figshare.23543296.v1figshare

Additional file 3 of Comparative characterization of Crimean-Congo hemorrhagic fever virus cell culture systems with application to propagation and titration methods

10.6084/m9.figshare.23543296figshare

Additional file 1 of Purification and characterization of soluble recombinant Crimean-Congo hemorrhagic fever virus glycoprotein Gc expressed in mammalian 293F cells

10.6084/m9.figshare.26860646.v1figshare

Additional file 1 of Purification and characterization of soluble recombinant Crimean-Congo hemorrhagic fever virus glycoprotein Gc expressed in mammalian 293F cells

10.6084/m9.figshare.26860646figshare

Additional file 2 of Comparative characterization of Crimean-Congo hemorrhagic fever virus cell culture systems with application to propagation and titration methods

10.6084/m9.figshare.23543293.v1figshare

Additional file 2 of Comparative characterization of Crimean-Congo hemorrhagic fever virus cell culture systems with application to propagation and titration methods

10.6084/m9.figshare.23543293figshare

Additional file 1 of Comparative characterization of Crimean-Congo hemorrhagic fever virus cell culture systems with application to propagation and titration methods

10.6084/m9.figshare.23543290figshare

Additional file 1 of Comparative characterization of Crimean-Congo hemorrhagic fever virus cell culture systems with application to propagation and titration methods

10.6084/m9.figshare.23543290.v1figshare